TY - JOUR T1 - Desensitization of Nicotinic Agonist-Induced [<sup>3</sup>H]γ-Aminobutyric Acid Release from Mouse Brain Synaptosomes Is Produced by Subactivating Concentrations of Agonists JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 1127 LP - 1134 VL - 291 IS - 3 AU - Ying Lu AU - Michael J. Marks AU - Allan C. Collins Y1 - 1999/12/01 UR - http://jpet.aspetjournals.org/content/291/3/1127.abstract N2 - Several neurochemical and electrophysiological studies have shown that neuronal nicotinic receptors are desensitized by pretreatment with lower agonist concentrations than are required to activate the receptors, but the extent of desensitization and agonist concentration required to produce desensitization vary depending upon receptor subtype. Recently, we reported that nicotinic agonists will stimulate the release of [3H]γ-aminobutyric acid (GABA) from synaptosomes prepared from mouse brain. The studies described herein evaluated desensitization of [3H]GABA release produced by pretreatment with 12 nicotinic agonists. Pretreatment produced near total desensitization that developed slowly (onsetT1/2 = 3.46 min) and was totally reversible (recovery T1/2 = 4.95 min). Nine of the 12 compounds tested induced total or near total desensitization at concentrations that were less than those required to produce a reliably measured increase in [3H]GABA release. Nicotine produced total block with an IC50 value of 26 nM. This value is two orders of magnitude lower than the EC50for nicotine-induced [3H]GABA release (1630 nM). The three compounds that showed an overlap of the desensitization and activation concentration-effect curves (cytisine, anabasine, nornicotine) are all partial agonists. Comparison of the desensitization properties of the [3H]GABA release with an ion (86Rb+) efflux that we have measured previously suggests that the receptor that mediates GABA release and86Rb+ efflux is the same, most likely the α4β2 subtype. The American Society for Pharmacology and Experimental Therapeutics ER -